Raymond James & Associates »

Arrowhead Pharmaceuticals shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $274k 9.6k 28.60
2023-12-31 $646k 21k 30.60
2023-09-30 $762k 28k 26.87
2023-06-30 $684k 19k 35.66
2023-03-31 $522k 21k 25.40
2022-12-31 $749k 19k 40.56
2022-09-30 $461k 14k 33.03
2022-06-30 $501k 14k 35.22
2022-03-31 $655k 14k 46.02
2021-12-31 $957k 14k 66.28
2021-09-30 $907k 15k 62.46
2021-06-30 $1.1M 13k 82.84
2021-03-31 $946k 14k 66.28
2020-12-31 $1.3M 16k 76.73
2020-09-30 $771k 18k 43.08
2020-06-30 $1.6M 37k 43.20
2020-03-31 $676k 24k 28.77
2019-12-31 $1.1M 17k 63.45
2019-09-30 $245k 8.7k 28.14
2016-06-30 $55k 10k 5.36